Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis.
Vierboom, M P M
Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. [electronic resource] - Clinical and experimental immunology Mar 2016 - 405-18 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2249
10.1111/cei.12739 doi
Abatacept--administration & dosage
Animals
Antirheumatic Agents--administration & dosage
Arthritis, Experimental
Arthritis, Rheumatoid--drug therapy
Autoimmunity--drug effects
C-Reactive Protein--metabolism
CD28 Antigens--antagonists & inhibitors
Collagen--immunology
Drug Administration Schedule
Female
Humans
Interleukin-6--blood
Lymphocyte Activation--drug effects
Macaca mulatta
Male
T-Lymphocytes--drug effects
Treatment Outcome
Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. [electronic resource] - Clinical and experimental immunology Mar 2016 - 405-18 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2249
10.1111/cei.12739 doi
Abatacept--administration & dosage
Animals
Antirheumatic Agents--administration & dosage
Arthritis, Experimental
Arthritis, Rheumatoid--drug therapy
Autoimmunity--drug effects
C-Reactive Protein--metabolism
CD28 Antigens--antagonists & inhibitors
Collagen--immunology
Drug Administration Schedule
Female
Humans
Interleukin-6--blood
Lymphocyte Activation--drug effects
Macaca mulatta
Male
T-Lymphocytes--drug effects
Treatment Outcome